Your statement validates Syrah announcement. Initial sales prices are low, as announced as customers test actual production deliveries. Syrah delivered test samples a year ago to many potential customers. Following this BTR and others moved ahead with agreements. Cardeza Labs has provided and continues to provide internal testing and validation. Syrah is at a late stage to have product successfully accepted and volume deliveries to follow. 90 days is not an unreasonable waiting period to get the successful nod.
Your Statement:
ALL commercially produced graphite concentrate has to be qualified even if the lab or pilot plant concentrate samples were initially given the node. No customer is going to change its product production parameters or BOM based on lab evals...even refractories require field trials of at least 2o MT of finished flake graphite to verify the commercially produced product meets the same performance metrics as the lab samples and this alone can take 90 days or more for refractory customer end user verification. If the concentrate falls short, NO SALES!
- Forums
- ASX - By Stock
- SYR
- Question Syrah must answer
Question Syrah must answer, page-24
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
22.5¢ | 23.0¢ | 21.5¢ | $1.244M | 5.635M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 116777 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 52000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 116062 | 1.070 |
10 | 209299 | 1.065 |
8 | 106613 | 1.060 |
6 | 96647 | 1.055 |
10 | 132219 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 58078 | 4 |
1.080 | 70753 | 4 |
1.085 | 72117 | 5 |
1.090 | 103210 | 6 |
1.095 | 57928 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online